Literature DB >> 17392304

Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants.

Leslie Hendeles1, Gene L Colice, Robert J Meyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392304     DOI: 10.1056/NEJMra050380

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Anesthetic agent vapor analyzers and propellants of pressurized meter-dose inhalers.

Authors:  Kavaraganahalli Mukundarao Deepak; Kiran Kini
Journal:  J Clin Monit Comput       Date:  2010-02-04       Impact factor: 2.502

2.  Effects of health literacy and cognitive abilities on COPD self-management behaviors: A prospective cohort study.

Authors:  Rachel O'Conor; Kimberly Muellers; Marina Arvanitis; Daniel P Vicencio; Michael S Wolf; Juan P Wisnivesky; Alex D Federman
Journal:  Respir Med       Date:  2019-02-14       Impact factor: 3.415

3.  The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma.

Authors:  Anupam B Jena; Oliver Ho; Dana P Goldman; Pinar Karaca-Mandic
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

Review 4.  Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008.

Authors:  Andrea J Apter
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

Review 5.  Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Authors:  Federico Lavorini; Claudia Mannini; Elisa Chellini; Giovanni A Fontana
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

Review 6.  Beta-Adrenergic Agonists.

Authors:  Giovanni Barisione; Michele Baroffio; Emanuele Crimi; Vito Brusasco
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30

7.  Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?

Authors:  Reed F Beall; Jason W Nickerson; Warren A Kaplan; Amir Attaran
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

Review 8.  U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations.

Authors:  Nadia Zuabi; Bhavesh Patel; Mark I Langdorf
Journal:  West J Emerg Med       Date:  2016-09-12

9.  The challenge of delivering therapeutic aerosols to asthma patients.

Authors:  Federico Lavorini
Journal:  ISRN Allergy       Date:  2013-08-05

Review 10.  Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Authors:  Mark L Levy; P N R Dekhuijzen; P J Barnes; M Broeders; C J Corrigan; B L Chawes; L Corbetta; J C Dubus; Th Hausen; F Lavorini; N Roche; J Sanchis; Omar S Usmani; J Viejo; W Vincken; Th Voshaar; G K Crompton; Soren Pedersen
Journal:  NPJ Prim Care Respir Med       Date:  2016-04-21       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.